Bikarma Singh

Title: Innovations of Bikarma Singh in Gastroretentive Drug Delivery

Introduction

Bikarma Singh, an inventive mind from Jammu, India, has made notable contributions to the field of pharmaceutical sciences. With a strong focus on drug delivery systems, his work is particularly aimed at improving treatment efficacy for inflammatory diseases.

Latest Patents

Bikarma Singh holds a patent for a novel gastroretentive swellable oral dosage form designed for the sustained or delayed release of bergenin, an active constituent extracted from specific plant sources. This innovation involves a unique process of preparing the dosage form by wet-granulating the extract with biodegradable and/or non-biodegradable polymers. The resulting granules can either be encapsulated in capsules or compressed into tablets. This formulation allows for a prolonged release of the bergenin extract in the stomach, lasting anywhere from 16 to 24 hours, thus enhancing therapeutic benefits in treating inflammatory conditions.

Career Highlights

Bikarma works at the Council of Scientific & Industrial Research, where he collaborates with some of the brightest minds in the field. His inventive efforts contribute to advancing pharmaceutical technologies, showcasing his commitment to research and development within the industry.

Collaborations

Throughout his career, Bikarma has partnered with talented individuals such as Sonali Sandip Bharate and Rohit Singh. These collaborations amplify his innovative efforts and foster an environment of shared knowledge and progress in scientific research.

Conclusion

In summary, Bikarma Singh’s innovative contributions in the realm of drug delivery systems exemplify the profound impact that dedicated inventors can have on healthcare. His patent addressing the sustained release of therapeutic agents signifies a promising advancement toward better management of inflammatory diseases.